ID

34603

Beskrivning

Performance of a Tablet Based Workflow and Decision Support System With Incorporated Software Algorithm Used for Glycaemic Management; ODM derived from: https://clinicaltrials.gov/show/NCT01766752

Länk

https://clinicaltrials.gov/show/NCT01766752

Nyckelord

  1. 2019-01-19 2019-01-19 -
  2. 2020-04-17 2020-04-17 -
  3. 2020-04-17 2020-04-17 - Sarah Riepenhausen
Rättsinnehavare

see on clinicaltrials.gov

Uppladdad den

19 januari 2019

DOI

För en begäran logga in.

Licens

Creative Commons BY-NC 3.0

Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Eligibility Type 2 Diabetes NCT01766752

Eligibility Type 2 Diabetes NCT01766752

Inclusion Criteria
Beskrivning

Inclusion Criteria

Alias
UMLS CUI
C1512693
informed consent obtained after being advised of the nature of the study
Beskrivning

ID.1

Datatyp

boolean

male or female aged 18 - 90 years (both inclusive)
Beskrivning

ID.2

Datatyp

boolean

type 2 diabetes treated with diet, oral agents, non-insulin injected anti-diabetic medicine, insulin therapy or any combination of the four
Beskrivning

ID.3

Datatyp

boolean

Exclusion Criteria
Beskrivning

Exclusion Criteria

Alias
UMLS CUI
C0680251
impaired renal function (serum creatinine ≥3.0mg/dl)
Beskrivning

ID.4

Datatyp

boolean

any disease or condition which the investigator or treating physician feels would interfere with the trial or the safety of the patient
Beskrivning

ID.5

Datatyp

boolean

pregnancy
Beskrivning

ID.6

Datatyp

boolean

any mental condition rendering the patient incapable of giving his consent
Beskrivning

ID.7

Datatyp

boolean

terminally ill patients
Beskrivning

ID.8

Datatyp

boolean

participation in a trial within 3 months prior to this trial
Beskrivning

ID.9

Datatyp

boolean

known or suspected allergy to insulin
Beskrivning

ID.10

Datatyp

boolean

Similar models

Eligibility Type 2 Diabetes NCT01766752

Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
informed consent obtained after being advised of the nature of the study
boolean
ID.2
Item
male or female aged 18 - 90 years (both inclusive)
boolean
ID.3
Item
type 2 diabetes treated with diet, oral agents, non-insulin injected anti-diabetic medicine, insulin therapy or any combination of the four
boolean
Item Group
C0680251 (UMLS CUI)
ID.4
Item
impaired renal function (serum creatinine ≥3.0mg/dl)
boolean
ID.5
Item
any disease or condition which the investigator or treating physician feels would interfere with the trial or the safety of the patient
boolean
ID.6
Item
pregnancy
boolean
ID.7
Item
any mental condition rendering the patient incapable of giving his consent
boolean
ID.8
Item
terminally ill patients
boolean
ID.9
Item
participation in a trial within 3 months prior to this trial
boolean
ID.10
Item
known or suspected allergy to insulin
boolean

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial